WO1994021307A1 - Matrix composition for tissue reinforcement and/or filling - Google Patents

Matrix composition for tissue reinforcement and/or filling Download PDF

Info

Publication number
WO1994021307A1
WO1994021307A1 PCT/SE1994/000222 SE9400222W WO9421307A1 WO 1994021307 A1 WO1994021307 A1 WO 1994021307A1 SE 9400222 W SE9400222 W SE 9400222W WO 9421307 A1 WO9421307 A1 WO 9421307A1
Authority
WO
WIPO (PCT)
Prior art keywords
poly
composition according
tissue
filling
matrix composition
Prior art date
Application number
PCT/SE1994/000222
Other languages
French (fr)
Inventor
Bengt ÅGERUP
Original Assignee
Medinvent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medinvent filed Critical Medinvent
Priority to EP94910629A priority Critical patent/EP0689464A1/en
Priority to AU62944/94A priority patent/AU6294494A/en
Publication of WO1994021307A1 publication Critical patent/WO1994021307A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/28—Bones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L29/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers of esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers
    • C08L29/02—Homopolymers or copolymers of unsaturated alcohols
    • C08L29/04—Polyvinyl alcohol; Partially hydrolysed homopolymers or copolymers of esters of unsaturated alcohols with saturated carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L35/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical, and containing at least one other carboxyl radical in the molecule, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L35/02—Homopolymers or copolymers of esters
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L39/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions of derivatives of such polymers
    • C08L39/04—Homopolymers or copolymers of monomers containing heterocyclic rings having nitrogen as ring member
    • C08L39/06—Homopolymers or copolymers of N-vinyl-pyrrolidones
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/04—Alginic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
    • C08L67/04—Polyesters derived from hydroxycarboxylic acids, e.g. lactones
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L75/00—Compositions of polyureas or polyurethanes; Compositions of derivatives of such polymers
    • C08L75/04—Polyurethanes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof

Abstract

The present invention relates to a matrix composition comprising a fibre of degradable biocompatible polymer. The matrix composition is rigid enough at 37 °C to hold against a negative tissue pressure of at least 2 cm H2O and at the most 50 cm H2O, and elastic enough to regain its shape after mechanical deformation. The matrix composition is used for tissue reinforcement nad/or filling.

Description

Matrix composition for tissue reinforcement an /υr filling
The present invention relates to a matrix composition for tissue reinforcement and/or filling.
Within the field of reconstructive surgery there is often a need to fill out or reinforce tissue. Normally bone from for example the iliac crest is transplanted to the area to be reinforced. This means that two surgical operations have to be performed on the same patient. Moreover, it is often desired to obtain a space for regenerating tissue such as nerves in nerve sheath or bone after surgery in the skull.
Modern membrane technology has enabled separation and isolation of tissue sections leading to development of the correct tissue type. This is for instance the case in controlled bone growth within oral surgical reconstruction or growth of skull and vertebra in neurosurgical reconstructions.
A common complication in connection with these membrane implanta¬ tions is that the tissue space to be regenerated collapses by the outer pressure effect in interaction with the so called negative tissue pressure. This condition has been observed and a number of methods have been developed to counteract these effects. For instance membranes have been designed being manufactured with molded spacers as described e.g. in WO90/07308.
Furthermore, bone cavities have been filled out with hydroxyapa- tite or deproteinized bone. In further other examples the membrane has been made extremely hard and strong to counteract collapse (for example BioFix). In all these cases, considerable inconveniences have arisen in use. Thus, a too hard membrane causes penetration through the mucous membrane or migrates in the body. Molded spacers have to be formed being perfectly adapted to the supporting membrane. Other examples, such as different types of filling materials, prevent the development of natural tissues. The present invention solves the above problems by providing a fiber comprising matrix composition creating a non-collapsible space in the tissue.
The composition according to the invention is rigid enough at 37βC to hold against a negative tissue pressure of at least 2 cm H20 and at the most 50 cm H20, and elastic enough to regain its shape following mechanical deformation.
The matrix is designed to follow the tissue closely. The solid implant pressure against which the matrix should hold mustn't be below the normal negative liquid pressure in the body, i.e. about 0,5-5 cm H20. The applicant has found that a negative liquid pressure of 2 cm H20 is a suitable lower limit for most applica¬ tions. On the other hand, the solid implant pressure against which the matrix should hold, must not be higher than about 50 cm H20 since such materials gives a too hard matrix which will penetrate the tissue and begin to migrate.
Preferably, the polymer fiber of the matrix composition according to the present invention is selected from the group consisting of polymeric butyric acid, polyglycolide and co-polymers thereof, polyactides and co-polymers thereof, poly-β-hydroxybutyrate and co-polymers thereof, poly-p-dioxanone, poly-δ-valerolactone, poly-€-caprolactone, methyl-metacrylate-N-vinyl pyrrolidine co- polymers, polyester amides, polyesters of oxalic acid, poly- dihydropyranes, polyalcyl-2-cyanoacrylates, polyurethanes, polyvinylalcohol, polypeptides, poly-β-maleic acid and poly-β- alcanoic acids and alginates.
The fibres of the matrix composition are made by an extruding process under known conditions. Another way of producing the fibres is by using the method described in applicants copending international application no. WO 92/21326, to which is referred.
The the solid implant pressure of the matrix composition according to the invention is measured by using the following method. For the measurement, there is used a balloon method similar to what is described by A.C. Guyton in Circ. Res. 16:452, 1965. Fifty mg of the solid matrix is introduced in a small rubber balloon. The balloon is filled with 50 ml of a buffered physiological water at 37°C and connected to a graded tube. The balloon with its content is put into a thermostated water bath (37βC) and the tube is fixed to a meter slide. The measurements are carried out by lowering the tube step by step thereby creating a negative fluid pressure in the balloon. The corre¬ sponding steady state change in volume at a fixed pressure decrease is read on the water column. The solid matrix pressure (P50) is the pressure under which the matrix can keep 50% of the free fluid volume as measured as the difference between the volume at zero pressure difference (VBajt) and at maximum concen¬ tration of the balloon (V_,in).
Another essential feature of the matrix composition according to the invention is that it is elastic enough to regain its shape after mechanical deformation.
According to another embodiment of the invention, the composition comprises therapeutically active agents, e.g. pharmacologically active agents such as growth modifying, bacteriostatic and cytostatic agents, and suitable combinations thereof. Preferably, the therapeutic agents are incorporated in the composition by impregnating the fibres with a solution active agents.
The invention will be described below in connection with some non-limiting examples.
EXAMPLE 1
To fill out a pit caused by an old vaccination on the upper arm of a young woman the skin was opened, the damaged skin section was removed and the subcutis tissue was filled out with a matrix made of bovine collagen fibers, which had previously been radiation sterilized for obtaining the correct properties. The healing occurred without complications and a natural tissue had developed upon control three months later.
The collagen material showed the following characteristics "in vitro" in physiological saline at 37°C after incubation for 24 hours. Solid implant pressure: 8 cm H20. Time for reshape following 50% deformation: 7 minutes.
EXAMPLE 2
An elderly woman had lost a large part of the edge of the alveolar bone and had begun to have problems in keeping her dentures. The mucous membrane was opened and small holes were drilled so that contact with the bone marrow was established. A ridge of extruded lactide polymer matrix was applied and over the matrix there was arranged a membrane of a copolymer of lactide/- glycolide covered with a thin layer of encapsulated tissue growth factor TGF-βl, in such a way that the matrix was completely covered. The dentures were designed so that a recess prevented a constant pressure initially over the surgical area.
After three months a hard tissue could be palpated. After six months there existed a bone on growth, which still kept its shape one year after the surgery.
In vitro measurements of the matrix 24 hours after incubation in 37"C water showed a solid implant pressure of 22 cm H20 and a return to the original shape after a 50% compression in 4 minutes.
EXAMPLE 3
In connection with planning for a dental fixture implantation it was found that the bone edge was too thin to completely cover a fixture. In connection with applying thereof, a matrix according to the invention and a membrane were placed over the bare threads on both sides of the bone edge. After six months the mucous membrane over the so called cover screw was opened and upon inspection of the area it was found that hard bone tissue had developed over and against the fixture. After another six months the fixture was still firmly anchored and the bone on-growth intact.
"In vitro" control of the matrix was after incubation in 37βC water for 24 hours. Solid implant pressure: 18 cm H20. Reshape after 50% compression: 2 minutes.
EXAMPLE 4
In connection with reconstruction of the skull bone after a traffic injury it was desired to regenerate the skull bone on the left edge of the front side. A raw connective tissue had been developed and after two years no bone development had occurred.
A gap, 20 mm long and 6 mm wide, needed bridging with bone. The raw connective tissue was removed and contact with intact bone surface and bone marrow was established.
The gap was filled with polylactide matrix and also a copolymer membrane (according to Example 2) was positioned covering the gap with an overlap of 10 mm. The membrane was attached and fixed with a degradable cement of copolymer. Upon a later control of the bone tissue the gap was found to be filled with bone-like hard tissue while the remaining raw connective tissue was intact.
In the above examples 2-4 and in other cases when it is required to cover the matrix, the patient's own as well as materials especially produced for this purpose may be used. In the latter case, a membrane and sealing agent of biodegradable type are preferably used as described in the applicant's international patent application publication No. W093/00936.

Claims

1. A tissue reinforcing and/or filling matrix composition, comprising fibres of degradable biocompatible polymer and being rigid enough at 37βC to hold against a negative tissue pressure of at least 2 cm H20 and at the most 50 cm H20, and elastic enough to regain its shape after mechanical deformation.
2. A composition according to claim 1, wherein the polymer is selected from the group consisting of polymeric butyric acid, polyglycolide and co-polymers thereof, polyactides and co- polymers thereof, poly-β-hydroxybutyrate and co-polymers thereof, poly-p-dioxanone, poly-δ-valerolactone, poly-e-caprolactone, methyl-metacrylate-N-vinyl pyrrolidine co-polymers, polyester amides, polyesters of oxalic acid, polydihydropyranes, poly- alcyl-2-cyanoacrylates, polyurethanes, polyvinylalcohol, poly- peptides, poly-β-maleic acid and poly-β-alcanoic acids and alginates.
3. A composition according to claims 1 or 2, also comprising a biologically degradable polymeric membrane.
4. A composition according to claim 3, also comprising a biologically degradable polymeric cement.
5. A matrix composition according to anyone of the claims 1-4, also comprising therapeutically active agent(s).
6. A matrix composition according to claim 5, wherein the active agent is selected among the group consisting of growth modifying, bacteriostatic and cytostatic agents or suitable combinations thereof.
7. Use of a matrix composition according to any of the claims 1-6 for tissue reinforcement and/or filling.
8. A method of tissue reinforcement and/or filling, comprising reinforcing and/or filling injured tissue with a composition according to anyone of the claims 1-7.
PCT/SE1994/000222 1993-03-15 1994-03-15 Matrix composition for tissue reinforcement and/or filling WO1994021307A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP94910629A EP0689464A1 (en) 1993-03-15 1994-03-15 Matrix composition for tissue reinforcement and/or filling
AU62944/94A AU6294494A (en) 1993-03-15 1994-03-15 Matrix composition for tissue reinforcement and/or filling

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9300852-2 1993-03-15
SE9300852A SE501183C2 (en) 1993-03-15 1993-03-15 Matrix composition for tissue strengthening and / or filling

Publications (1)

Publication Number Publication Date
WO1994021307A1 true WO1994021307A1 (en) 1994-09-29

Family

ID=20389232

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE1994/000222 WO1994021307A1 (en) 1993-03-15 1994-03-15 Matrix composition for tissue reinforcement and/or filling

Country Status (4)

Country Link
EP (1) EP0689464A1 (en)
AU (1) AU6294494A (en)
SE (1) SE501183C2 (en)
WO (1) WO1994021307A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5588960A (en) * 1994-12-01 1996-12-31 Vidamed, Inc. Transurethral needle delivery device with cystoscope and method for treatment of urinary incontinence

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990007308A1 (en) * 1988-12-23 1990-07-12 Procordia Oratech Ab Surgical barrier
WO1993000936A1 (en) * 1991-06-17 1993-01-21 Medinvent A barrier for tissue separation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990007308A1 (en) * 1988-12-23 1990-07-12 Procordia Oratech Ab Surgical barrier
WO1993000936A1 (en) * 1991-06-17 1993-01-21 Medinvent A barrier for tissue separation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5588960A (en) * 1994-12-01 1996-12-31 Vidamed, Inc. Transurethral needle delivery device with cystoscope and method for treatment of urinary incontinence

Also Published As

Publication number Publication date
SE501183C2 (en) 1994-12-05
AU6294494A (en) 1994-10-11
SE9300852D0 (en) 1993-03-15
EP0689464A1 (en) 1996-01-03
SE9300852L (en) 1994-09-16

Similar Documents

Publication Publication Date Title
US6132214A (en) Medical implant
US5002583A (en) Collagen implants
US5158934A (en) Method of inducing bone growth using TGF-β
US4186448A (en) Device and method for treating and healing a newly created bone void
US6878383B2 (en) Compositions for regenerating tissue that has deteriorated, and methods for using such compositions
US3982543A (en) Reducing capillarity of polyglycolic acid sutures
EP0466820B1 (en) Articles for treating periodontal disease and bone defects
AU671721B2 (en) Tgf-beta formulation for inducing bone growth
US7879107B2 (en) Composition and method for inducing bone growth and healing
US6065476A (en) Method of enhancing surface porosity of biodegradable implants
JPH0683713B2 (en) Surgical barrier
McVicar et al. Self-reinforced polyglycolic acid membrane: a bioresorbable material for orbital floor repair. Initial clinical report
KR100488405B1 (en) Bio-resorbable nerve conduit and method for preparing the same
Song et al. Biomimetic characteristics of mussel adhesive protein-loaded collagen membrane in guided bone regeneration of rabbit calvarial defects
WO1999060951A1 (en) Compositions for regenerating tissue that has degenerated, and methods for using such compositions
CN1258591C (en) Tissue engineered peripheral nerve graft
Fontana et al. Freeze‐dried dura mater for guided tissue regeneration in post‐extraction dental implants: a clinical and histologic study
US6406711B1 (en) Bone regeneration material
RU2367475C1 (en) Membrane to be used in targeted angiogenesis
CN108283732B (en) Bone grafting composite material for alveolar bone increment
JP3695511B2 (en) Bone regeneration material
WO1994021307A1 (en) Matrix composition for tissue reinforcement and/or filling
Sank et al. Cellular responses to silicone and polyurethane prosthetic surfaces
US9833544B2 (en) Biphasic collagen membrane or capsule for guided tissue regeneration
CN109847103A (en) A kind of artificial blood vessel and preparation method thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1994910629

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1994910629

Country of ref document: EP

ENP Entry into the national phase

Ref country code: US

Ref document number: 1996 525529

Date of ref document: 19960111

Kind code of ref document: A

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1994910629

Country of ref document: EP